Hyperion DeFi (NASDAQ:HYPD) Trading Up 3.9% – What’s Next?

Hyperion DeFi, Inc. (NASDAQ:HYPD)’s share price rose 3.9% on Monday . The company traded as high as $3.21 and last traded at $3.18. Approximately 275,886 shares were traded during trading, a decline of 65% from the average daily volume of 790,228 shares. The stock had previously closed at $3.06.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on the company. Chardan Capital reduced their price objective on Hyperion DeFi from $8.25 to $7.30 and set a “buy” rating on the stock in a research note on Monday, June 8th. Zacks Research downgraded Hyperion DeFi from a “hold” rating to a “strong sell” rating in a report on Monday, March 30th. Weiss Ratings raised Hyperion DeFi from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, June 24th. Finally, Cantor Fitzgerald increased their price target on Hyperion DeFi from $4.00 to $6.60 and gave the company an “overweight” rating in a research report on Wednesday. Two investment analysts have rated the stock with a Buy rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $6.95.

Hyperion DeFi Price Performance

The stock has a market cap of $47.60 million, a PE ratio of -0.32 and a beta of 2.47. The firm has a fifty day moving average of $3.53 and a 200 day moving average of $3.50. The company has a quick ratio of 1.97, a current ratio of 1.97 and a debt-to-equity ratio of 0.12.

Insider Activity

In other Hyperion DeFi news, insider Hyunsu Jung acquired 7,000 shares of the stock in a transaction dated Monday, June 1st. The stock was acquired at an average cost of $3.70 per share, with a total value of $25,900.00. Following the transaction, the insider owned 1,384,676 shares in the company, valued at $5,123,301.20. The trade was a 0.51% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 7.50% of the company’s stock.

Institutional Investors Weigh In On Hyperion DeFi

Several institutional investors have recently added to or reduced their stakes in the business. Sanctuary Advisors LLC acquired a new position in Hyperion DeFi in the fourth quarter valued at approximately $38,000. Nations Financial Group Inc. IA ADV purchased a new stake in shares of Hyperion DeFi during the 4th quarter worth approximately $40,000. Price T Rowe Associates Inc. MD purchased a new stake in shares of Hyperion DeFi during the 4th quarter worth approximately $73,000. Formidable Asset Management LLC acquired a new position in shares of Hyperion DeFi in the 4th quarter valued at $83,000. Finally, State Street Corp acquired a new position in shares of Hyperion DeFi in the 4th quarter valued at $92,000. Hedge funds and other institutional investors own 25.84% of the company’s stock.

About Hyperion DeFi

Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.